Showing results 18 to 31 of 31
< previous
Issue Date | Title | Author(s) |
2021-01 | Molecular exploration of combinational therapy of orlistat with metformin prevents the COVID-19 consequences in obese diabetic patients. | Singh, Y; Gupta, G; Anand, K; Kumar Jha, N; Thangavelu, L; Kumar Chellappan, D; Dua, K |
2021-12 | Natural products in the management of obesity: Fundamental mechanisms and pharmacotherapy | Chan, Y; Ng, SW; Tan, JZX; Gupta, G; Negi, P; Thangavelu, L; Balusamy, SR; Perumalsamy, H; Yap, WH; Singh, SK; Caruso, V; Dua, K; Chellappan, DK |
2023-10-25 | New horizons in lung cancer management through ATR/CHK1 pathway modulation. | Thapa, R; Afzal, O; Bhat, AA; Goyal, A; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Kazmi, I; Singh, SK; Dua, K; Thangavelu, L; Gupta, G |
2022-02 | Nuclear factor-kappa B (NF-κB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases | Alharbi, KS; Afzal, O; almalki, WH; Kazmi, I; Javed Shaikh, MA; Thangavelu, L; Gulati, M; Singh, SK; Jha, NK; Gupta, PK; Chellappan, DK; Oliver, BG; Dua, K; Gupta, G |
2021-06 | Nuclear factor-kappa B and its role in inflammatory lung disease | Alharbi, KS; Fuloria, NK; Fuloria, S; Rahman, SB; Al-Malki, WH; Javed Shaikh, MA; Thangavelu, L; Singh, SK; Rama Raju, VS; Jha, NK; Chellappan, DK; Dua, K; Gupta, G |
2019-08-01 | Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases | Mehta, M; Deeksha; Tewari, D; Gupta, G; Awasthi, R; Singh, H; Pandey, P; Chellappan, DK; Wadhwa, R; Collet, T; Hansbro, PM; Kumar, SR; Thangavelu, L; Negi, P; Dua, K; Satija, S |
2019-09-01 | The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress | Dua, K; Wadhwa, R; Singhvi, G; Rapalli, V; Shukla, SD; Shastri, MD; Gupta, G; Satija, S; Mehta, M; Khurana, N; Awasthi, R; Maurya, PK; Thangavelu, L; Rajeshkumar, S; Tambuwala, MM; Collet, T; Hansbro, PM; Chellappan, DK |
2022-01-03 | PREVENTIVE ROLE OF SAPINDUS SPECIES IN DIFFERENT NEUROLOGICAL AND METABOLIC DISORDERS | Rawat, S; Gupta, G; Mishra, A; Pathak, S; Thangavelu, L; Singh, SK; Jha, NK; Kumar, D; Negi, P; Kumar, AP; Chellappan, DK; Dua, K |
2021-01 | Recent update on barbiturate in relation to brain disorder. | Pathak, S; Gupta, G; Thangavelu, L; Singh, SK; Dua, K; Chellappan, DK; Gilhotra, RM |
- | Role of HGF/MET in liver cancer | Gupta, G; Al-Malki, WH; Kazmi, I; Thangavelu, L; Gupta, PK; Jha, NK; Prasher, P; Singh, SK; Dua, K |
2022-03-17 | Role of Nanoparticles in Environmental Remediation: An Insight into Heavy Metal Pollution from Dentistry | Thangavelu, L; Veeraragavan, GR; Mallineni, SK; Devaraj, E; Parameswari, RP; Syed, NH; Dua, K; Chellappan, DK; Balusamy, SR; Bhawal, UK |
2021-02 | Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. | Lee, L-Y; Hew, GSY; Meenu,; Shukla, SD; Satija, S; Khurana, N; Anand, K; Dureja, H; Singh, SK; Mishra, V; Singh, PK; Gulati, M; Prasher, P; Aljabali, AAA; Tambuwala, MM; Thangavelu, L; Panneerselvam, J; Gupta, G; Zacconi, FC; Shastri, M; Jha, NK; Xenaki, D; MacLoughlin, R; Oliver, BG; Chellappan, DK; Dua, K |
2022-02 | Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models | Tan, CL; Chan, Y; Candasamy, M; Chellian, J; Madheswaran, T; Sakthivel, LP; Patel, VK; Chakraborty, A; MacLoughlin, R; Kumar, D; Verma, N; Malyla, V; Gupta, PK; Jha, NK; Thangavelu, L; Devkota, HP; Bhatt, S; Prasher, P; Gupta, G; Gulati, M; Singh, SK; Paudel, KR; Hansbro, PM; Oliver, BG; Dua, K; Chellappan, DK |
2023-08 | Unveiling the connection: long-chain non-coding RNAs and critical signaling pathways in breast cancer | Thapa, R; Afzal, O; Kumar, G; Bhat, AA; Almalki, WH; Alzarea, SI; Kazmi, I; Altamimi, ASA; Subramaniyan, V; Thangavelu, L; Singh, SK; Dua, K |